Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 395

1.

AMY-1, a novel C-MYC binding protein that stimulates transcription activity of C-MYC.

Taira T, Maëda J, Onishi T, Kitaura H, Yoshida S, Kato H, Ikeda M, Tamai K, Iguchi-Ariga SM, Ariga H.

Genes Cells. 1998 Aug;3(8):549-65.

2.
3.

c-Myc/Max heterodimers bind cooperatively to the E-box sequences located in the first intron of the rat ornithine decarboxylase (ODC) gene.

Walhout AJ, Gubbels JM, Bernards R, van der Vliet PC, Timmers HT.

Nucleic Acids Res. 1997 Apr 15;25(8):1493-501.

4.

CDC6 interacts with c-Myc to inhibit E-box-dependent transcription by abrogating c-Myc/Max complex.

Takayama M, Taira T, Iguchi-Ariga SM, Ariga H.

FEBS Lett. 2000 Jul 14;477(1-2):43-8.

5.

Do products of the myc proto-oncogene play a role in transcriptional regulation of the prothymosin alpha gene?

Mol PC, Wang RH, Batey DW, Lee LA, Dang CV, Berger SL.

Mol Cell Biol. 1995 Dec;15(12):6999-7009.

6.

Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc.

Desbarats L, Gaubatz S, Eilers M.

Genes Dev. 1996 Feb 15;10(4):447-60.

8.

N and C-terminal sub-regions in the c-Myc transactivation region and their joint role in creating versatility in folding and binding.

Fladvad M, Zhou K, Moshref A, Pursglove S, Säfsten P, Sunnerhagen M.

J Mol Biol. 2005 Feb 11;346(1):175-89. Epub 2004 Dec 10.

PMID:
15663936
9.

Activation domains of L-Myc and c-Myc determine their transforming potencies in rat embryo cells.

Barrett J, Birrer MJ, Kato GJ, Dosaka-Akita H, Dang CV.

Mol Cell Biol. 1992 Jul;12(7):3130-7.

10.

Max: functional domains and interaction with c-Myc.

Kato GJ, Lee WM, Chen LL, Dang CV.

Genes Dev. 1992 Jan;6(1):81-92.

12.

Transcriptional activation by Myc is under negative control by the transcription factor AP-2.

Gaubatz S, Imhof A, Dosch R, Werner O, Mitchell P, Buettner R, Eilers M.

EMBO J. 1995 Apr 3;14(7):1508-19.

13.

New Myc-interacting proteins: a second Myc network emerges.

Sakamuro D, Prendergast GC.

Oncogene. 1999 May 13;18(19):2942-54. Review.

14.

Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif.

Hurlin PJ, Steingrìmsson E, Copeland NG, Jenkins NA, Eisenman RN.

EMBO J. 1999 Dec 15;18(24):7019-28. Erratum in: EMBO J 2000 Jul 17;19(14):3841.

15.

Identification of a novel Krüppel-associated box domain protein, Krim-1, that interacts with c-Myc and inhibits its oncogenic activity.

Hennemann H, Vassen L, Geisen C, Eilers M, Möröy T.

J Biol Chem. 2003 Aug 1;278(31):28799-811. Epub 2003 May 13.

16.

MM-1, a c-Myc-binding protein, is a candidate for a tumor suppressor in leukemia/lymphoma and tongue cancer.

Fujioka Y, Taira T, Maeda Y, Tanaka S, Nishihara H, Iguchi-Ariga SM, Nagashima K, Ariga H.

J Biol Chem. 2001 Nov 30;276(48):45137-44. Epub 2001 Sep 20.

17.

Interaction of c-Myc with the pRb-related protein p107 results in inhibition of c-Myc-mediated transactivation.

Beijersbergen RL, Hijmans EM, Zhu L, Bernards R.

EMBO J. 1994 Sep 1;13(17):4080-6.

18.

Cloning of a human gene closely related to the genes coding for the c-myc single-strand binding proteins.

Penkov D, Ni R, Else C, Piñol-Roma S, Ramirez F, Tanaka S.

Gene. 2000 Feb 8;243(1-2):27-36.

PMID:
10675610
19.

MSSP promotes ras/myc cooperative cell transforming activity by binding to c-Myc.

Niki T, Izumi S, Saëgusa Y, Taira T, Takai T, Iguchi-Ariga SM, Ariga H.

Genes Cells. 2000 Feb;5(2):127-41.

20.

USF/c-Myc enhances, while Yin-Yang 1 suppresses, the promoter activity of CXCR4, a coreceptor for HIV-1 entry.

Moriuchi M, Moriuchi H, Margolis DM, Fauci AS.

J Immunol. 1999 May 15;162(10):5986-92.

Supplemental Content

Support Center